{
    "clinical_study": {
        "@rank": "102442", 
        "arm_group": [
            {
                "arm_group_label": "SS-PCI", 
                "arm_group_type": "Active Comparator", 
                "description": "Same sitting multivessel PCI as an adjunct to primary PCI"
            }, 
            {
                "arm_group_label": "IRA-PCI", 
                "arm_group_type": "Active Comparator", 
                "description": "IRA only PCI with planned staging for non-IRA lesions"
            }
        ], 
        "brief_summary": {
            "textblock": "Revascularization strategies for ST elevation myocardial infarction (STEMI) study (The\n      ASSIST-MI Trial) will compare the effects of two revascularization strategies [same sitting\n      multivessel primary PCI (SS-PCI) and culprit vessel only primary PCI (IRA-PCI)] on\n      myocardial infarct size (MIS) as determined by cardiac magnetic resonance (CMR) imaging in\n      patients presenting with STEMI and multivessel disease (MVD)."
        }, 
        "brief_title": "Revascularization Strategies for ST Elevation Myocardial Infarction Trial: The ASSIST-MI Trial", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  High risk ST elevation myocardial infarction evidenced by: \u22652 mm ST elevation in 2\n             anterior or lateral leads; or \u22652 mm ST elevation in 2 inferior coupled with ST\n             depression in 2 contiguous anterior leads for a total ST deviation of \u22658 mm; or New\n             left bundle branch block with at least 1 mm concordant ST elevation.\n\n          -  Multivessel CAD as evidenced by \u22651 significant (\u226570% by visual assessment or FFR<0.80\n             for 50-70% stenosis) stenosis in non-IRA.\n\n          -  Successful IRA-PCI with <10% residual angiographic stenosis and TIMI III flow.\n\n          -  Written informed consent.\n\n        Exclusion Criteria:\n\n          -  Age \u2264 18 years.\n\n          -  Prior coronary artery bypass graft (CABG) surgery.\n\n          -  Administration of thrombolytic therapy.\n\n          -  Non-IRA stenosis is a chronic total occlusion or located in left main artery.\n\n          -  Hemodynamic instability evidenced by BP<90 mmHg, Killip class \u22652, need for\n             inotropes/vasopressors.\n\n          -  Known renal insufficiency (estimated GFR < 50ml/min).\n\n          -  Contraindication to CMR."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01818960", 
            "org_study_id": "AC-103"
        }, 
        "intervention": [
            {
                "arm_group_label": "IRA-PCI", 
                "description": "IRA only PCI at the time of Primary PCI", 
                "intervention_name": "IRA-PCI", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "SS-PCI", 
                "description": "Same sitting multivessel PCI as an adjunct to primary PCI", 
                "intervention_name": "SS-PCI", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Stent, Myocardial Infarction, Angioplasty, Coronary Intervention", 
        "lastchanged_date": "May 23, 2013", 
        "location": {
            "contact": {
                "email": "cheemaA@smh.ca", 
                "last_name": "Asim Cheema, MD", 
                "phone": "416-864-5739"
            }, 
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5B 1W8"
                }, 
                "name": "St. Michael's hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Revascularization Strategies for ST Elevation Myocardial Infarction Trial", 
        "other_outcome": {
            "measure": "LV function", 
            "safety_issue": "No", 
            "time_frame": "90 days and one year"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Infarct size by CMR", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01818960"
        }, 
        "responsible_party": {
            "investigator_affiliation": "St. Michael's Hospital, Toronto", 
            "investigator_full_name": "Asim Nazir Cheema", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "MACE rate at 12 months", 
            "measure": "MACE rate", 
            "safety_issue": "Yes", 
            "time_frame": "One year"
        }, 
        "source": "St. Michael's Hospital, Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Michael's Hospital, Toronto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}